IMC Chicago
LEGN icon

IMC Chicago’s Legend Biotech LEGN Stock Holding History

IMC Chicago’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17,894
Closed -$483K – 6585
2026
Q1 		$324K Sell
17,894
-5,051
-22% -$96.3K ﹤0.01% 4508
2025
Q4 		$499K Buy
+22,945
New +$657K ﹤0.01% 3481

Other funds holding LEGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MICM
Matthews International Capital Management San Francisco, California $292M AUM 75.01% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
IAMH
IvyRock Asset Management (HK) Sheung Wan, Hong Kong $177M AUM 10.49% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
ELI
Empire Life Investments Toronto, Ontario, Canada $1.79B AUM 38.49% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

IMC Chicago's LEGN Position: Q2 2026 in Review

IMC Chicago sold out of Legend Biotech (LEGN) in Q2 2026, closing a stake of 17,894 shares — an estimated $483K sold.

IMC Chicago first reported a position in LEGN in Q4 2025 and held it in 2 quarters. The position peaked at $499K in Q4 2025. 79 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • IMC Chicago reported no remaining Legend Biotech position as of Q2 2026 after selling out during the quarter.
  • IMC Chicago sold 17,894 Legend Biotech shares in Q2 2026, an estimated $483K.
  • IMC Chicago first reported a position in Legend Biotech in Q4 2025 and held it in 2 quarters.
  • IMC Chicago's Legend Biotech position peaked at $499K in Q4 2025.
  • 79 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.